Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to Advocate Illinois Masonic Medical Center · Chicago, Illinois
Answer a few short questions to share with the research team.